Document:

EXHIBIT 10.2

                         EXTENSION OF FARMOUT AGREEMENT

     For and in consideration of mutual benefits,  detriments,  and promises the
adequacy  of which is hereby  acknowledged,  the  parties,  Sharon K. Fowler and
Garner Investments, Inc., agree as follows:

     1)   That  Farmout  Agreement  by and  between  the  parties  upon  Lease #
          06-00321 dated August 29, 2006, is hereby  extended until December 31,
          2009.

     2)   All other  terms and  conditions  thereof  remain in force and  effect
          except as to the extended date of 4 (B).

Garner Investments, Inc.                          Sharon K. Fowler

by ___________________________                    by ___________________________
PresidentEXHIBIT 10.1

     

    EXHIBIT
10.1

     

    
      MERGER
TERMINATION AND RELEASE AGREEMENT

      

       

      THIS
MERGER TERMINATION AND RELEASE AGREEMENT, dated as of April 17, 2008 (this
“Merger Termination
Agreement”), is entered into by and among Virium Holdings, Inc., a
Delaware corporation (“Holdings”), Virium
Pharmaceuticals Inc., a New York corporation and a wholly-owned subsidiary of
Holdings (the “Company”), REIT
Americas, Inc., a Maryland corporation (“RAI”), Virium
Pharmaceuticals, Inc., a Delaware corporation and direct, wholly-owned
subsidiary of RAI (“Pharmaceuticals”) and
Virium Merger Sub, Inc., a Delaware corporation and direct, wholly-owned
subsidiary of Pharmaceuticals (“Merger Sub”) and
Dawson James Securities, Inc. (“Dawson”).

       

      WHEREAS,
the parties previously entered into an Agreement and Plan of Merger dated as of
May 25, 2007, as amended (the “Merger Agreement”),
by and among the Company, RAI, Pharmaceuticals and Merger Sub pursuant to which
the Company would be merged with and into Merger Sub (the “Merger”);

       

      WHEREAS,
the parties no longer wish to consummate the Merger and mutually desire to
terminate the Merger Agreement pursuant to the terms and conditions more fully
set forth below; and

       

      WHEREAS,
the Company wishes to consider entering into an acquisition transaction (the
“Third Party
Transaction”) with a third party (the “Third Party”)
followed by an equity financing transaction;

       

      NOW,
THEREFORE, in consideration of the mutual agreements contained herein and for
other good and valuable consideration, the receipt and sufficiency of which are
hereby acknowledged, the parties hereto agree as follows:

      

      1.           Termination.  Effective
upon the execution hereof, the Merger Agreement shall be terminated, void and of
no further force or effect, and no party to the Merger Agreement shall have any
liability to any other person for any claim with respect to any provision
thereof, whether such claim arose prior to or after the date hereof, other than
pursuant to the provisions of Section 5.7 of the Merger Agreement.

      

      2.           Third Party
Release.  Effective upon execution hereof, the Third Party
involved in the Third Party Transaction shall have no liability whatsoever for
any claims, liabilities or other damages arising under, or pursuant to, the
Merger Agreement and related transaction documents or otherwise based upon, or
related to the termination of the Merger Agreement and transactions contemplated
thereby and/or the pursuit or entry into any Third Party
Transaction.

      

      3.           Termination
Payment.  If both the Third Party Transaction and the Qualified
Financing (as defined in Section 7 below) are consummated, then the Company
shall promptly pay to RAI, subject to Section 3 below, $535,000 cash (the “Termination Amount”),
in immediately available funds, by wire transfer to RAI pursuant to wire
instructions to be provided by RAI, which upon such consummation shall be the
sole and exclusive payment obligation of the Company with respect to the Merger
Agreement.

      

      
        
           

        

        
           

          
            

          

        

        
           

        

         

      

      4.           Stock
Payment.  The Company may, at its sole and absolute discretion,
discharge $300,000 of the Termination Amount by issuing to RAI 718,257 (as
adjusted for stock splits, stock combinations, stock dividends and the like, the
“Share Amount”)
shares of the Company’s common stock, par value $0.001 per share (the “Stock Payment”);
provided, however, that if the
Company consummates the Third Party Transaction and, pursuant to the terms
thereof, shares of common stock of the successor or acquiring corporation in
such Third Party Transaction are received by or distributed to the holders of
the Company Common Stock in exchange therefor, then the Company (or its
successor or the acquiring corporation, as applicable) may thereafter make the
Stock Payment by delivering to RAI that number of shares of common stock of the
successor or acquiring corporation in the Third Party Transaction that would
have been received by a holder of that number of shares of Common Stock that is
equal to the Share Amount.  Nothing in this Merger Termination
Agreement shall be deemed to create any obligation on the part of the Company or
any successor or acquiring corporation to pay any portion of the Termination
Amount in stock or other securities.

      

      5.           Name
Change.  Promptly following the execution of this Merger
Termination Agreement, RAI, Pharmaceuticals and Merger Sub shall take such
action and execute such further certificates, instruments, documents and
agreements as may be reasonably requested by the Company in order either
dissolve or change the names of Pharmaceuticals and Merger Sub such that they no
longer contain the word “Virium”.  RAI, Pharmaceuticals and Merger Sub
hereby acknowledge and agree that as between them and the Company, the Company
has all rights, title and interest in the name “Virium”.

      

      6.           Dawson
Shares.

      

      (a)   
Issuance of Dawson
Shares.  Promptly following the execution hereof, Holdings
shall issue to Dawson 1,675,933 shares of its common stock, par value $0.001 per
share, (the “Dawson
Shares”) in lieu of the shares of common stock, par value $0.001 per
share, of the Company that would have been issued to Dawson upon the closing of
the transactions pursuant to the Merger Agreement.  Forty percent
(40%) of the Dawson Shares shall vest immediately upon issuance thereof (the
“Vested
Shares”) and the remaining sixty percent (60%) of the Dawson Shares shall
be restricted shares (the “Restricted
Shares”).

      

      (b)   
Vesting;
Restrictions.  The Restricted Shares shall vest upon the
consummation of a Qualified Financing (the time of such consummation, the “Vesting
Time”).  Until the Vesting Time, neither the Restricted Shares
nor any right or privilege pertaining thereto may be sold, transferred,
assigned, pledged, hypothecated or otherwise disposed of or encumbered in any
way, by operation of law or otherwise, and shall not be subject to execution,
attachment or similar process.  Upon any attempt to transfer, assign,
pledge, hypothecate or otherwise dispose of or encumber the Restricted Shares or
any right or privilege pertaining thereto, the Restricted Shares and all rights
and privileges given hereby shall immediately terminate and the Restricted
Shares shall be forfeited to Holdings pursuant to paragraph 6(c)
hereof.

      

      
        
           

        

        
          2

          
            

          

        

        
           

        

         

      

      (c)   
Forfeiture.

       

      (i)   
All of Dawson’s rights to, and interest in, the Restricted Shares shall
terminate and be forfeited to Holdings without payment of consideration if a
Qualified Financing is not consummated on or prior to the Closing Deadline (as
defined below).

       

      (ii)   
If at any time Dawson forfeits any Restricted Shares pursuant to this Merger
Termination Agreement, Dawson agrees to return the certificate or certificates
for such Restricted Shares to Holdings duly endorsed in blank or accompanied by
a stock power duly executed in blank.

      

      (d)   
Representations and
Warranties of Dawson; Legends.

       

      (i)   
In connection with the issuance of the Dawson Shares, Dawson hereby represents
and warrants to Holdings that (A) Dawson is acquiring the Dawson Shares for its
own account for investment and not with a view to, or for sale in connection
with, any distribution thereof, nor with the intention of distributing or
reselling the same, (B) Dawson is aware that none of the Dawson Shares have been
registered under the Securities Act of 1933, as amended (the “Securities Act”), or
under applicable state securities or blue sky laws and (C) Dawson is an
“Accredited Investor” as such term is defined in Rule 501 of Regulation D, as
promulgated under the Securities Act.

       

      (ii)   
Dawson acknowledges and agrees that the certificates representing the Dawson
Shares shall bear a customary legend restricting the sale thereof other than in
compliance with the Securities Act and applicable state securities or blue sky
laws and that the certificate representing the Restricted Shares shall bear an
additional legend to the effect that any transfer or disposition thereof is
subject to the restrictions set forth in this Merger Termination
Agreement.

      

      (e)   
Issuance or
Distribution of Third Party Stock.  If at any time following,
or in connection with, a Third Party Transaction, shares of common stock of the
Third Party are issued or distributed to Dawson in respect of the Restricted
Shares, whether directly by the Third Party or by Holdings, (any such shares,
“Restricted Third
Party Shares”), then all of the provisions (including, without limitation
the restrictions) set forth in this Section 6 (other than the provisions of
Section 6(a)) shall inure to the benefit of the Third Party and shall apply to
such Restricted Third Party Shares mutatis mutandis such that
the term “Restricted Shares” as used in such provisions shall be deemed to refer
to the Restricted Third Party Shares and the term “Holdings” as used in such
provisions shall be deemed to refer to the Third
Party.  Notwithstanding any such application of the provisions of this
Section 6 to Restricted Third Party Shares, such provisions shall simultaneously
apply to Restricted Shares that remain outstanding.

      

      7.           Certain Defined
Terms.  For purposes of this Merger Termination
Agreement:

       

      (a) 
  “Closing
Deadline” shall mean the later of (i) June 12, 2008 and (ii) the New
Maturity Date;

       

      
        
           

        

        
          3

          
            

          

        

        
           

        

         

      

      (b) 
  “New Maturity
Date” shall mean the date to which all of the maturity dates of the
Second Bridge Notes (as defined in Schedule A) are
extended, if, prior to June 12, 2008 the Third Party, with the assistance of
Dawson, is able to negotiate an extension of the maturity dates of all of the
Second Bridge Notes, on terms and conditions reasonably satisfactory to the
Third Party; and

       

      (c)   
“Qualified
Financing” shall mean an equity financing transaction by the Third Party
with a closing date no later than the Closing Deadline and gross proceeds to the
Third Party from investors introduced to the Third Party by Dawson James
Securities, Inc. of not less than an amount equal to $2,500,000 reduced by the
principal amounts of any Bridge Notes set forth on Schedule A hereto
that are fully converted into equity securities of the Third Party on or prior
to the closing date of such equity financing transaction.

       

      8.           Counterparts.  This
Merger Termination Agreement may be executed in two or more counterparts, each
of which shall be deemed an original but which together shall constitute one and
the same instrument.  The executed signature pages hereto may be
delivered by facsimile or other means of electronic image transmission, such a
copy of any signature page hereto shall have the same force an effect as an
original thereof.

       

      9.           Governing
Law.  This Merger Termination Agreement shall be governed by,
and construed in accordance with, the laws of the State of New York without
reference to principles of conflicts of law.

    

    
      
         

         

         [Signature Page
Follows]

        

        
          
            
            

          

          
            4

            
              

            

          

          
            
            

          

        

        

        IN WITNESS WHEREOF, the parties hereto
have executed this Merger Termination Agreement as a document under seal as of
the date first above written.

         

      

    

    
      
        
          
            
              
                
                  	 	 	 
	 	Virium Pharmaceuticals Inc.
      
	 
 	 
 	 
 
	 	By:  	
                          /s/
      James M. Pachence

                        
	 	
                          
    
	 	
                          Name:
      James M. Pachence

                          Title:
      President

                        

                

                
                  

                  
                    	 	 	 
	 	REIT Americas,
      Inc.
	 
 	 
 	 
 
	 	By:  	
                            
                              /s/
      F. Dale Markham

                            

                          
	 	
                            
    
	 	
                            
                              Name:
      F. Dale Markham

                            

                            Title:
      President

                          

                  

                  

                  
                    	 	 	 
	 	
                            Virium Pharmaceuticals, Inc.
      (Delaware)

                          
	 
 	 
 	 
 
	 	By:  	
                            
                              /s/
      F. Dale Markham

                            

                          
	 	
                            
    
	 	
                            
                              Name:
      F. Dale Markham

                            

                            Title:
      President

                          

                  

                  

                  
                    	 	 	 
	 	Virium Merger Sub,
      Inc.
	 
 	 
 	 
 
	 	By:  	
                            
                              /s/
      F. Dale Markham

                            

                          
	 	
                            
    
	 	
                            
                              Name:
      F. Dale Markham

                            

                            Title:
      President

                          

                     

                    
                      
                        
                        

                      

                      
                        5

                        
                          

                        

                      

                      
                        
                        

                      

                    

                  

                

                 

                
                  
                    
                      	 	 	Virium
      Holdings, Inc. 
	 
 	 
 	 
	 	 	
                              
                                      
                                  /s/
      James M. Pachence

                                

                              

                            
	 	
                              
    
	 	
                              
                                Name: James
      M. Pachence

                              

                              Title:
      President

                            

                    

                    
                      

                      
                        	 	 	      
                                Dawson
      James Securities, Inc. 

                              
	 
 	 
 	 
 
	 	 	
                                
                                        
                                    /s/
      Frank
      N. Salvatore

                                  

                                

                              
	 	
                                
    
	 	
                                
                                  Name: Frank
      N. Salvatore

                                

                                Title:
      Managing Partner

                              

                      

                       

                       

                       

                       

                      

                      
                        [Signature
Page to Merger Termination Agreement]

                        

                        
                          
                             

                          

                          
                            6

                            
                              

                            

                          

                          
                             

                          

                        

                        

                         

                        Schedule A
to

                         

                        Merger Termination
Agreement

                         

                        Bridge
Notes

                         

                         

                        “Bridge Notes”
pursuant to the Merger Termination Agreement shall include all of the
following:

                         

                         

                        First
Bridge Notes

                         

                        The
following note issued by the Company pursuant to the Subscription Agreement
dated as of May 30, 2007 by and between the Company and Strategic Capital
Resources, Inc.:

                         

                        
                          	
                                  Name

                                	 	
                                  Amount
      of Note

                                	 	
                                  Note
      Number

                                
	 	 	 	 	 
	
                                  Strategic
      Capital Resources, Inc.

                                	 	
                                  $500,000

                                	 	
                                  PN-May-1

                                

                        

                         

                         

                        Second
Bridge Notes

                         

                        The
following notes (the “Second Bridge Notes”)
issued by the Company pursuant to the Subscription Agreement dated as of
December 12, 2007 by and between the Company and each of the following
persons:

                         

                        
                          	
                                  Name

                                	 	
                                  Amount
      of Note

                                	 	
                                  Note
      Number

                                
	 	 	 	 	 
	
                                  Paul
      Cartmell

                                	 	
                                  $
      25,000

                                	 	
                                  PN-Dec07-1

                                
	 	 	 	 	 
	
                                  Arthur
      Dunkin

                                	 	
                                  $
      25,000

                                	 	
                                  PN-Dec07-2

                                
	 	 	 	 	 
	
                                  Jack
      Garson

                                	 	
                                  $
      50,000

                                	 	
                                  PN-Dec07-3

                                
	 	 	 	 	 
	
                                  Kevin
      Lemack

                                	 	
                                  $
      50,000

                                	 	
                                  PN-Dec07-4

                                
	 	 	 	 	 
	
                                  SCO
      Capital Partners, LLC

                                	 	
                                  $
      50,000

                                	 	
                                  PN-Dec07-6

                                
	 	 	 	 	 
	
                                  SCO
      Capital Partners, L.P

                                	 	
                                  $
      175,000

                                	 	
                                  PN-Dec07-7

                                
	 	 	 	 	 
	
                                  Buddy
      Smith

                                	 	
                                  $
      100,000

                                	 	
                                  PN-Dec07-5

                                
	 	 	 	 	 
	
                                  Mindy
      Wardlaw

                                	 	
                                  $
      25,000

                                	 	
                                  PN-Dec07-8

                                

                        

                        

                        
                          
                             

                          

                          
                            7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00141-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00141-of-00352.parquet"}]]